-+ 0.00%
-+ 0.00%
-+ 0.00%

ProKidney names Kenneth Locke chief technical officer

PUBT·06/02/2026 12:06:47
Listen to the news
ProKidney names Kenneth Locke chief technical officer
  • ProKidney named Kenneth Locke as chief technical officer as it prepares for a pivotal topline readout for rilparencel in Q2 2027.
  • Locke joins from Carisma Therapeutics, where he led CMC, quality, regulatory functions, and technical strategy for first-in-human CAR myeloid programs.
  • He previously held cell-therapy manufacturing and supply-chain leadership roles at Celgene, now Bristol Myers Squibb, and at Novartis.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prokidney Corp. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.